Temporal Dynamics of the Plasma Proteomic Landscape Reveals Maladaptation in ME/CFS Following Exertion.
Germain, Arnaud, Glass, Katherine A, Eckert, Melissa A et al. · Molecular & cellular proteomics : MCP · 2025 · DOI
Quick Summary
Researchers studied what happens in the blood of ME/CFS patients during and after exercise to understand post-exertional malaise (PEM)—the worsening of symptoms that occurs after physical activity. They measured over 6,000 different proteins in 79 ME/CFS patients and 53 healthy controls before exercise, immediately after, and during recovery. They found that ME/CFS patients have abnormal protein changes during recovery that suggest their immune system and energy-producing cells are not working properly after exertion.
Why It Matters
This is the first large-scale longitudinal proteomics study specifically designed to capture the molecular mechanisms of PEM in real-time. By identifying specific immune and metabolic abnormalities that occur during post-exertional symptom flares, the findings provide concrete targets for developing treatments and diagnostic biomarkers for ME/CFS—potentially moving beyond symptom management toward disease-modifying interventions.
Observed Findings
ME/CFS patients showed suppression of T cell and B cell signaling proteins during recovery, consistent with immune exhaustion.
IL-17 and cell-cell communication pathways were downregulated in ME/CFS following exertion, whereas glycolysis/gluconeogenesis pathways were upregulated, suggesting mitochondrial insufficiency.
Protein abundance in ME/CFS patients was discordant with exercise capacity metrics (VO2max, anaerobic threshold) compared to controls.
Immune-related protein changes correlated with symptom severity, particularly myalgia, recurrent sore throat, and lymph node tenderness.
Females and males with ME/CFS exhibited distinct molecular response profiles to exercise.
Inferred Conclusions
ME/CFS involves a maladaptive proteomic response to exertion characterized by impaired immune recovery and metabolic dysregulation, distinguishing it from deconditioning alone.
Mitochondrial stress and immune dysfunction are central to PEM pathophysiology and represent potential intervention targets.
Dynamic proteomic profiling over time is more informative than cross-sectional measurements for understanding ME/CFS biology.
Remaining Questions
Do the identified protein changes directly cause PEM symptoms, or are they secondary markers of an upstream pathological process?
What This Study Does Not Prove
This study does not prove that these protein changes *cause* PEM or that correcting them will cure ME/CFS—only that they are associated with exertion-induced symptom worsening. The findings are correlative, not mechanistic, and require functional studies to determine whether these proteins are drivers or consequences of the dysregulation. Sex-specific differences are observed but not explained by underlying mechanisms in this study.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.